Manufacturer
Sanofi Vaccines
Pharmaceutical manufacturer based in France
France
- Products listed
- 21
- Molecules
- 19
- Therapy areas
- 1
Sanofi Vaccines is a pharmaceutical manufacturer based in France. MedsAcross lists 21 of its products across 19 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- France
- Indian manufacturer
- No
- Also listed as
- Sanofi Vaccines US Inc.
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Sanofi Vaccines products through licensed channels, with the documents your regulator needs.
Immunoglobulins
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Beyfortus 100 mg/1 mL injectionIntramuscular Cold chain | Nirsevimab | US FDA | Available on request |
| Beyfortus 50 mg/0.5 mL injectionIntramuscular Cold chain | Nirsevimab | US FDA | Available on request |
Other products
19 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| ActHIB kit | Haemophilus influenzae type b strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen | US FDA | Available on request |
| Adacel TDaP injectable suspensionIntramuscular | Clostridium tetani toxoid antigen (formaldehyde inactivated), corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen | US FDA | Available on request |
| Daptacel injectable suspensionIntramuscular | Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen | US FDA | Available on request |
| Diluent injectionSubcutaneous | Sodium chloride | US FDA | Available on request |
| Flublok Trivalent Northern Hemisphere injectionIntramuscular | Influenza a virus a/missouri/11/2025 (h1n1) recombinant hemagglutinin antigen, influenza a virus a/darwin/ (h3n2) recombinant hemagglutinin antigen, and influenza b virus b/pennsylvania/14/2025 recombinant hemagglutinin antigen | US FDA | Available on request |
| Fluzone HD Tiv SH 2026 injectable suspensionIntramuscular | Influenza a virus a/switzerland/ ivr-278 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/singapore/gp20238/2024 ivr-277 (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/michigan/01/2021 antigen (formaldehyde inactivated) | US FDA | Available on request |
| Fluzone High Dose Northern Hemisphere injectable suspensionIntramuscular | Influenza a virus a/switzerland/ ivr-278 (a/missouri/11/2025 pdm09-like virus) (h1n1) antigen (formaldehyde inactivated), influenza a virus a/michigan/105/2025 san-049a (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/tokyo/eis13-175/2025 antigen (formaldehyde inactivated) | US FDA | Available on request |
| Fluzone Tiv SH 2026 injectable suspensionIntramuscular | Influenza a virus a/switzerland/ ivr-278 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/singapore/gp20238/2024 ivr-277 (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/michigan/01/2021 antigen (formaldehyde inactivated) | US FDA | Available on request |
| Fluzone Trivalent Northern Hemisphere injectable suspensionIntramuscular | Influenza a virus a/switzerland/ ivr-278 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/michigan/105/2025 san-049a (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/tokyo/eis13-175/2025 antigen (formaldehyde inactivated) | US FDA | Available on request |
| Imovax Rabies kit | Rabies virus strain pm-1503-3m antigen (propiolactone inactivated) and water | US FDA | Available on request |
| Ipol injectable suspensionIntramuscular | Poliovirus type 1 antigen (formaldehyde inactivated), poliovirus type 2 antigen (formaldehyde inactivated), and poliovirus type 3 antigen (formaldehyde inactivated) | US FDA | Available on request |
| Menactra injectionIntramuscular | Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen, neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen, neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen, and neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen | US FDA | Available on request |
| MenQuadfi injectionIntramuscular | Neisseria meningitidis group a capsular polysaccharide tetanus toxoid conjugate antigen, neisseria meningitidis group c capsular polysaccharide tetanus toxoid conjugate antigen, neisseria meningitidis group y capsular polysaccharide tetanus toxoid conjugate antigen, and neisseria meningitidis group w-135 capsular polysaccharide tetanus toxoid conjugate antigen | US FDA | Available on request |
| Nuvaxovid 2026-27 injectable suspensionIntramuscular | Nvx-cov2928 | US FDA | Available on request |
| Quadracel injectable suspensionIntramuscular | Diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine | US FDA | Available on request |
| Tenivac injectable suspensionIntramuscular | Clostridium tetani toxoid antigen (formaldehyde inactivated) and corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) | US FDA | Available on request |
| Tubersol 5 IU/0.1 mL injectionIntradermal Cold chain | Tuberculin purified protein derivative | US FDA | Available on request |
| Typhim Vi injectionIntramuscular | Salmonella typhi ty2 vi polysaccharide antigen | US FDA | Available on request |
| Yf-vax powder for injectable suspensionSubcutaneous | Yellow fever virus strain 17d-204 live antigen | US FDA | Available on request |
Molecules made
Haemophilus influenzae type b strain 1482 capsular polysaccharide tetanus toxoid conjugate antigenClostridium tetani toxoid antigen (formaldehyde inactivated), corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigenNirsevimabCorynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigenSodium chlorideInfluenza a virus a/missouri/11/2025 (h1n1) recombinant hemagglutinin antigen, influenza a virus a/darwin/ (h3n2) recombinant hemagglutinin antigen, and influenza b virus b/pennsylvania/14/2025 recombinant hemagglutinin antigenInfluenza a virus a/switzerland/ ivr-278 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/singapore/gp20238/2024 ivr-277 (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/michigan/01/2021 antigen (formaldehyde inactivated)Influenza a virus a/switzerland/ ivr-278 (a/missouri/11/2025 pdm09-like virus) (h1n1) antigen (formaldehyde inactivated), influenza a virus a/michigan/105/2025 san-049a (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/tokyo/eis13-175/2025 antigen (formaldehyde inactivated)Influenza a virus a/switzerland/ ivr-278 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/michigan/105/2025 san-049a (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/tokyo/eis13-175/2025 antigen (formaldehyde inactivated)Rabies virus strain pm-1503-3m antigen (propiolactone inactivated) and waterPoliovirus type 1 antigen (formaldehyde inactivated), poliovirus type 2 antigen (formaldehyde inactivated), and poliovirus type 3 antigen (formaldehyde inactivated)Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen, neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen, neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen, and neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigenNeisseria meningitidis group a capsular polysaccharide tetanus toxoid conjugate antigen, neisseria meningitidis group c capsular polysaccharide tetanus toxoid conjugate antigen, neisseria meningitidis group y capsular polysaccharide tetanus toxoid conjugate antigen, and neisseria meningitidis group w-135 capsular polysaccharide tetanus toxoid conjugate antigenNvx-cov2928Diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccineClostridium tetani toxoid antigen (formaldehyde inactivated) and corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)Tuberculin purified protein derivativeSalmonella typhi ty2 vi polysaccharide antigenYellow fever virus strain 17d-204 live antigen
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Sanofi Vaccines
Send a request for any of these products. We confirm the licensed source, documents and lead time.